ODDB.org: Open Drug Database

Tocilizumab Spirig HC 200 mg/10 ml, Konzentrat zur Herstellung einer Infusionslösung - 4

Swissmedic Key	69925010	Registration Holder	Spirig HealthCare AG
Name	Tocilizumab Spirig HC 200 mg/10 ml, Konzentrat zur Herstellung einer Infusionslösung	Date of registration	21.05.2025
		Introduction of Sequence	21.05.2025
ATC-Classification	Tocilizumab (L04AC07)	Revision date
WHO	WHO-DDD	Valid until	20.05.2030
Index Therapeuticus (BSV)	70000.	Show package size	4
Index Therapeuticus (Swissmedic)	07.15.	Description
Swissmedic categorie.	A
SL Eintrag	No	Indication
Information for professionals	IP	Consumer information

Deductible	k.A.
Feedback	FB
GTIN	7680699250103	Medication Code	Biotechnologika
Pharmacode		Disponibility

Composition

tocilizumabum 200 mg, histidinum, histidini hydrochloridum monohydricum, arginini hydrochloridum, saccharum, polysorbatum 80, aqua ad iniectabile q.s. ad solutionem pro 10 ml.

Packungsbestandteile

Galenic Form

Concentrate for infusion

Excipiens

Active Agent	Dose
Tocilizumabum	200mg / 10ml

BAG: Active Agent	Dose
Tocilizumabum	200 mg

Inactive agents
Arginine Hydrochloride
Histidin Hydrochloride Monohydrate
Histidine
Polysorbatum 80
Saccharum

Source

Data was imported : 08.07.2026 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :

2026	©ywesee GmbH